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Purpose: To evaluate long-term visual outcome of arteriovenous adventitial sheathotomy in BRVO-induced 
macular edema.
Methods: The visual outcomes of 8 patients following vitrectomy with arteriovenous adventitial sheathotomy 
for BVO-induced macular edema (surgery group) were retrospectively evaluated. The three‐year 
post-operative visual acuity of the surgery group was compared with that of the conservatively managed 
controls. 
Results: All patients were followed for a minimum of 36 months. Mean BCVA (logMAR) in the surgery group 
changed from 1.10±0.34 to 1.19±0.70 and to 0.80±0.36 at 12 and 36 months, respectively (p=0.959 at 
12 months, p=0.018 at 36 months). In the control group, visual acuity improved from 1.15±0.43 to 0.43±
0.44 and to 0.43±0.39 at 12 and 36 months, respectively (p=0.015 at 12 months, at p=0.003 at 36 months). 
A strong trend toward better visual acuity at 12 months and final examination was observed for controls. 
(surgery vs. control group, p=0.052 at 12 months, p=0.066 at 36 months).
Conclusions: Considering the favorable natural course of BVO and the unproven effect of reperfusion on 
macular edema, surgical efficacy of arteriovenous adventitial sheathotomy requires further evaluation.
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Branch retinal vein occlusion (BRVO) is the second most 
common retinal vascular disease. BRVO can lead to visual 
loss from retinal hemorrhage, macular edema, and macular 
ischemia. Although BRVO has a relatively favorable visual 
prognosis, with approximately 50% of patients achieving 
20/50 and reasonable final visual acuity, some patients’ 
acuities worsen. Previous reports suggest that poor initial 
acuity, macular ischemia, and foveal avascular zone 
breakdown predict poor outcome.
1,2 However, there is 
controversy regarding the etiology of poor outcome.
The branch vein occlusion study showed that argon laser 
macular photocoagulation benefits those with macular edema 
lasting longer than 3 months prior to treatment, foveal 
avascular zone preservation, and no macular hemorrhage.
3 
However, most patients had initial acuities between 20/40 
and 20/100, and very few patients with severe visual loss 
were enrolled. Therefore, alternative treatments for BRVO 
patients with poor initial acuity are needed.
BRVO is thought to be caused by vein compression at an 
arteriovenous crossing site. Arteries share a common 
arteriovenous sheath with the vein; an overlying hypertensive 
and atherosclerotic affected artery leads to compression, 
downstream venous turbulence, endothelial damage, and 
secondary thrombosis. Arteriovenous adventitial sheathotomy 
has been proposed as a direct approach to release 
compressive vein force and to restore venous flow. To date, 
surgical results show resolution of macular edema and 
subsequent visual improvement.
4-7 However, there is some 
controversy regarding surgical efficacy and long-term 
outcome.
This study, therefore, retrospectively reviewed visual 
outcomes of arteriovenous adventitial sheathotomy at 3 year 
follow-up in patients with BRVO-induced macular edema 
and poor visual acuity.
Materials and Methods
A consecutive series of patients with BRVO associated 
decreased visual acuity from September 2002 to December 
2003 were enrolled. All patients with retinal disease other 
than BRVO were excluded. Patients with 20/100 or worse Kor  J  Ophthalmol  Vol.22,  No.1,  2008
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Characteristics Sheathotomy  (n=8) Control  (n=8) p-value
*
Age  (yrs) 58±10 66±6 0.083
Gender 
    Male 3  (37.5%) 4  (50  %) 0.214
    Female 5  (62.5%) 4  (50  %)
Hypertension 8  (100%) 5  (62.5%) 0.200
Location  of  BRVO
    Superior 6  (75%) 3  (37.5%) 0.315
    Inferior 2  (25%) 5  (62.5%)
Severity  of  macular  ischemia
    <  90  degree 4  (50%) 4  (50%)
    >  90  degree 4  (50%) 4  (50%)
* p-value=Comparison  between  two  groups,  Fisher’s  exact  test  /  Mann-Whitney  test.
Table  1.  Baseline  Characteristics
best‐corrected visual acuity (BCVA) were eligible and were 
followed for at least 3 years. Patients were not excluded 
based on fluorescein angiographic evidence of capillary 
nonperfusion or extensive hemorrhage involving the fovea. In 
addition, patients were not excluded by symptom duration or 
BRVO location.
All patients initially underwent complete ophthalmologic 
examination including BCVA, fundus photographs, and 
fluorescein angiography. The macular Photocoagulation 
Study disc areas were used to quantify ischemia size from 
fluorescein angiograms. Best-corrected visual acuity was 
measured and recorded with a decimal notation.
One surgeon performed surgical procedures. After standard 
pars plana vitrectomy, surgical separation of the posterior 
cortical vitreous from optic nerve and posterior retina was 
performed. The responsible arteriovenous (AV) crossing site 
was identified. A modified microvitreoretinal blade, bent at 
the tip, was used to separate the overlying artery from vein. 
An inner retinal incision was started between 100 and 500 
µm proximal to the AV crossing. The incision was continued 
parallel to, and under the retinal arteriole, with gentle lifting 
motion, until it reached the common AV crossing sheath. 
Both sides of the blade were used in a side-to-side manner 
to incise through the arteriovenous sheath and to separate the 
arteriole from underlying venule. The end point was elevation 
of the arteriole from the underlying venule.
Patients were examined postoperatively at 1 day, 1 week, 
and at monthly intervals for 6 months, followed by quarterly 
examinations thereafter. Postoperative examinations included 
best corrected visual acuity, slit-lamp examination, tonometry, 
and fundus examination.
Patients who had 20/100 or worse initial visual acuity and 
did not have surgical intervention were enrolled as controls, 
and observed for at least 36 months. The control group was 
examined at monthly intervals for 6 months after diagnosis, 
then at intervals of 2 to 3 months.
Decimal visual acuity was converted to a logarithm 
of minimal angle of resolution for statistical analysis. 
Improvement or worsening of visual acuity in surgery group 
was analyzed with Wilcoxon-signed rank test. Pearson 
correlation coefficient was used to analyze whether visual 
prognosis was associated with degree of foveal ischemia, 
timing of surgical intervention, initial visual acuity or 
macular thickness. Comparisons of baseline variables, visual 
acuity and vision change between two groups were performed 
using Mann-Whitney test and Fisher’s exact test. A value of 
p<0.05 was considered statistically significant.
Results
Eight eyes from 8 patients with macular edema secondary to 
BRVO and with decreased visual acuity to 20/100 underwent 
vitrectomy with arteriovenous adventitial sheathotomy. All 
patients completed 36 months of follow-up examinations. 
Eight control eyes completed 36 month follow-up. Baseline 
variables were compared between surgery and control groups 
including age, gender, initial visual acuity, hypertension, 
BRVO location (superior or inferior), and fluorescein 
angiographic findings of severity of foveal ischemia. Table 
1 summarizes baseline characteristics. The surgery and 
control group were statistically similar with respect to 
baseline variables.
The duration of BRVO before arteriovenous sheathotomy 
was between 1 and 13 months (mean±std, 3.95±3.8 Mo) 
in the surgery group. The arteriole was found to overlay 
the venule in all patients. The intraoperative surgical 
decompression of the arteriovenous crossing site (as defined 
by successful separation of the overlying arteriole from 
venule) was achieved in all surgical patients. Removal of 
internal limiting membrane was performed in all patients.
In the surgery group, vision changed from 1.10±0.34 to 
1.19±0.70 at 12 months and to 0.80±0.36 at 36 months. 
The mean visual acuity change in logMAR between the 
initial and final examination was 0.30±0.28, and the final 
BCVA was significantly better than preoperative BCVA 
(p=0.018). IK  Oh,  et  al.  ARTERIOVENOUS  ADVENTITIAL  SHEATHOTOMY  ON  BRVO
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Characteristics Sheathotomy  (n=8) Control  (n=8) p-value
*
Initial  VA
†
    0.1-0.2 4  (50%) 4  (50%) -
    <  0.1 4  (50%) 4  (50%)
    Mean  VA  (logMAR) 1.10±0.34 1.15±0.43 0.814
12  months  VA
†
  ≥ 0.5 0   5  (62.5%) 0.052
    0.1-0.4 4  (50%) 2  (25%)
    <  0.1 4  (50%)   1  (12.5%)
    Mean  VA  (logMAR) 1.19±0.70 0.43±0.44 0.052
36  months  VA
†
  ≥ 0.5     1  (12.5%)   6  (62.5%) 0.018
    0.1-0.4 6  (75%)   1  (12.5%)
    <  0.1     1  (12.5%)   1  (12.5%)
    Mean  VA  (logMAR) 0.80±0.36 0.43±0.39 0.066
Change  in  VA  between  initial  visit  and  final  visit  (%)
    Improved 6  (75%)   7  (87.5%) -
    Unchanged     1  (12.5%)   1  (12.5%)
  W o r s e n e d   1  ( 1 2 . 5 % ) 0
  M e a n  c h a n g e  ( l o g M A R ) 0 . 3 0 ±0.28 0.72±0.47 0.053
(p=0.018)
‡ (p=0.003)
‡
* p- v a l u e :  C o m p a r i s o n  b e t w e e n  t w o  g r o u p s ,  F i s h e r ’s  exact  test  /  Mann-Whitney  test; 
†Visual  acuity:  Decimal  visual  acuity; 
‡p-value: 
C o m p a r i s o n  o f  v i s u a l  a c u i t y  ( l o g M A R )  b e t w e e n  i n i t i a l  v i s i t  a n d  final  visit,  Wilcoxon  signed  rank  test.
Table  2.  Summary  of  visual  outcome
Visual acuity change
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Fig.  1.  Change  in  visual  acuity  since  the  initial  visit.
*  p- v a l u e :  C o m p a r i s o n  b e t w e e n  t w o  g r o u p s ,  p=0.052  at  12 
months,  p=0.066  at  36  months.
P*=0.066
Timing of surgical intervention and degree of foveal 
ischemia were not statistically significant with respect to 
vision improvement (p=0.865 and p=0.686). Patients with 
better preoperative visual acuity had a strong trend toward 
better final acuity (p=0.063). In postoperative OCT at a mean 
of 34 months, the mean thickness of the foveal center (±SD) 
was 204.7±46.9 µm. However, this decrease was not 
accompanied with visual acuity improvement and there was 
no correlation between final visual acuity and foveal 
thickness (p=0.618).
In the control group, visual acuity improved from 1.15± 
0.43 to 0.43±0.44 and to 0.43±0.39 at 12 and 36 months, 
respectively (vs. initial vision, p=0.015 at 12 months, 
p=0.003 at 36 months). Comparison of the surgery and 
control groups was performed using the mean BCVA at 
initial, 12 month, and final examination, and visual acuity of 
20/40 or better (Table 2). Both groups were statistically 
similar with respect to initial visual acuity (p=0.814). 
However, a strong trend toward better visual acuity with the 
control group at 12‐month and final examination was 
observed (surgery vs. control group, p=0.052 at 12 months, 
p=0.066 at 36 months) (Fig. 1). Changes in visual acuity 
between the initial and 36‐month examination was also 
greater in the control group, but was not statistically 
significant. (surgery vs. control group, 0.30±0.28 vs. 0.72±
0.47, p=0.053). At final examination, 62.5% of controls had 
20/40 or better, compared with 12.5% in the surgery group 
(p=0.018).
Cataract developed in 7 of 8 eyes in the surgery group, 
and phacoemulsification with intraocular lens implantation 
was performed approximately 20.1 (±14.4) months after 
surgery.
Discussion
Arteriovenous adventitial sheathotomy involving pars 
plana vitrectomy and AV crossing decompression is a direct 
approach to reopen involved venule. Osterloh and Charles.
8 
first performed the procedure in a patient who obtained visual 
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improvement from 20/200 to 20/25, with progressive 
intraretinal hemorrhage and macular edema resolution 8 
months post‐operation. Since then, several studies have 
reported arteriovenous adventitial sheathotomy outcomes. 
However, there has been controversy regarding its efficacy. 
The primary goal of sheathotomy is to reestablish compressed 
venule perfusion. However, it is unclear if reperfusion 
decreases macular edema. Yamamoto et al.
9 performed 
arteriovenous adventitial sheathotomy in 20 eyes and obtained 
reperfusion in 10 eyes. However, correlation between 
reperfusion and macular edema or visual acuity improvement 
was not established. In addition, surgical separation of the 
posterior vitreous cortex alone showed similar outcomes. 
Charbonnel et al.
4 also reported that postoperative 
improvement in visual acuity was due to macular edema 
decrease and not from better blood flow.
On the other hand, a correlation between postoperative 
macular thickness and visual acuity was consistently reported 
in many studies. Garcia-Arumi et al.
5 reported a significant 
correlation between decreased macular edema and visual 
acuity improvement (p<0.001, r=-0.725). Cahill et al.
10 also 
reported that improved acuity was achieved only in eyes with 
resolved macular edema. In addition, it was demonstrated that 
intravitreal injection of triamcinolone acetonide leads to both 
decreased macular thickness and improved visual acuity, 
regardless of nonischemic or ischemic type.
11 It appears that 
improvement in vision occurs with macular edema resolution. 
However, resolution does not always lead to vision 
improvement. In the present study, postoperative central 
foveal thickness at a mean of 34 months was 195.6±58.6 
µm (range from 94 to 258 µm) and macular edema almost 
disappeared in all cases. However, this decrease was not 
accompanied with visual acuity improvement and OCT foveal 
structure was disorganized in most of the surgery group.
In a 15-patient study following arteriovenous adventitial 
sheathotomy, Opremcak and Bruce.
12 reported that 80% had 
stable vision or visual improvement. Mester and Dillinger.
7 
performed sheathotomy on 43 patients with BRVO and used 
25 patients as controls. Visual acuity improved from 0.16 to 
0.35 (decimal notation), and 60% of patients achieved more 
than 2 lines of improvement. Yamamoto et al.
9 reported that 
visual acuity improved from 0.53±0.35 to 0.25±0.28 
(logMAR, vision improvement 0.29±0.35). Kumagai et al.
13 
also showed significant improvement at 31 months after 
sheathotomy (logMAR, improvement from 0.52±0.45 to 
0.08±0.18). In the present study, visual acuity changed from 
1.10±0.34 to 0.80±0.36 (at 36 month, p=0.018) and visual 
acuity improvement was 0.30±0.28. The final visual acuity 
in the present study was worse than those of other studies. 
However, this may be due to worse initial visual acuity. 
Vision improvement in our study, with an average of 0.30 
logMAR of vision gained, was similar to that of study by 
Yamamoto et al. and in 6 of 8 eyes in the surgery group had 
improved vision after surgery.
With regard to surgical timing, an association between 
early intervention and better visual outcomes has previously 
been described. Mason et al.
6 showed a strong trend toward 
improved visual outcomes with early intervention and Mester 
and Dillingers.
7 reported that best functional improvement 
was observed in eyes with a shorter duration of symptoms. 
In the present study, timing of surgical intervention were not 
statistically significant with respect to vision improvement 
(p=0.865). However, 2 patients with symptom duration of 1 
month had a tendency toward better visual outcome than 
patients with longer duration (vision improvement, 0.59±
0.01 vs. 0.11±0.05, p=0.071). These results show that early 
sheathotomy may be more effective than delayed 
intervention. The fact that symptom duration was longer in 
our patients may also be another explanation for worse visual 
acuity than other studies. (15.8 weeks in the present study 
vs. 6.0 weeks in other studies).
There is conflicting evidence of an association between 
preoperative fluorescein angiographic findings of foveal 
ischemia and visual acuity outcomes. Mason et al.
6 reported 
that foveal capillary nonperfusion and foveal ischemia 
severity had a statistically significant association with 
worsening of visual acuity. In contrast, Charbonnel et al.
4 
reported that eyes with preoperative retinal ischemia had 
more favorable outcomes than those without. In the present 
study, there was no significant association between the 
degree of macular ischemia and vision improvement.
Compared with patients in the surgery group, controls had 
a tendency toward better visual outcome at each time point. 
Cataract progressed in 7 of 8 eyes in the surgery group and 
cataract surgery was performed at a mean of 20 months after 
the operation. However, even after cataract surgery, vision 
remained poor in the surgery group. Although patients were 
not randomly assigned to treatment groups, and precise 
comparison between surgical intervention and natural course 
may not be possible, the difference in visual outcome 
between two groups was considerable.
Given the uncertainty of the reperfusion effect on visual 
improvement, the frequent complications, such as cataract 
progression, and the favorable natural course of BRVO, 
arteriovenous adventitial sheathotomy may be not a better 
treatment modality than conservative management in all 
cases. However, arteriovenous adventitial sheathotomy may 
be promising in selective cases. In the present study, one 
patient who had experienced gradual deterioration in visual 
acuity over 12 months before surgery achieved vision 
improvement from 1.16 to 0.82 (logMAR, change of 0.33) 
after surgery. Since the mean vision improvement of other 
patients in our study was 0.22±0.31, this patient’s 
improvement was noteworthy.
This study had several limitations including a small sample 
size and nonrandomized treatment allocation. However, 
positive aspects of this study included more than three years 
of follow-up study, the presence of a control group, and 
consistent surgical technique by single surgeon.
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reperfusion effect on macular edema have created doubt 
regarding arteriovenous adventitial sheathotomy efficacy. 
Prospective randomized clinical trials are needed to determine 
efficacy and to evaluate indications for good surgical results. 
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